Stockholders' Equity (Details) - USD ($)			1 Months Ended			3 Months Ended		12 Months Ended
	Feb. 02, 2018	Aug. 14, 2017	Jan. 31, 2021	Dec. 31, 2018	Oct. 24, 2017	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2017	Dec. 31, 2020	Oct. 16, 2017
Stockholders' Equity (Details) [Line Items]
Conversion price (in Dollars per share)										$ 0.05
Number of shares issued						132,000
Amount warrants issued (in Dollars)		$ 5						$ 93,312
Warrants exercise price (in Dollars per share)		$ 0.15
Value of shares converted (in Dollars)						$ 8,624
Aggregate value of conversion of units (in Dollars)						$ 1,374,871
Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued	5,500,000
Amount warrants issued (in Dollars)				$ 226,833
Warrants exercise price (in Dollars per share)					$ 0.15
Stock price (in Dollars per share)					$ 1,000,000
Warrant expiration term					5 years
Number of shares issued on debt conversion	2,750,000
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares converted						677,903,545
Aggregate value of conversion of units (in Dollars)						$ 52,880
Conversion of shares						52,879,636
Conversion of stock, description						During January 2021, the Company issued 75,000,000 shares of its common stocks in exchange for 100% of the outstanding shares of its Series A Preferred Stock. The terms of the exchange were different than the original terms of the Series A Preferred stock resulting in a non-cash loss to the Company of $1,735,500. During January 2021, the Company issued 20,052,000 shares of its common stock to a related party in full payment of a trade accounts payable totaling $20,052. As a result of this settlement, the Company recorded a non-cash loss of $501,300. During January 2021, the Company issued 32,827,636 shares of its common stock to a related party in full payment for past CEO and other consulting services rendered totaling $361,104. As a result of this settlement, the Company recorded a non-cash loss of $492,415. During January 2021, the Company issued 43,860,545 shares of its common stock to a related party in full payment of a loans totaling $404,500 and related accrued interest totaling $77,966. During January 2021, the Company issued 320,855,533 shares of its common stock to a related party in full payment of loans totaling $2,101,000 and related accrued interest totaling $264,523. During January 2021, the Company issued 39,836,667 shares of its common stock to a related party in full payment of a loan totaling $200,000 and related accrued interest totaling $42,044. During January 2021, the Company issued 273,350,500 shares of its common stock to a related party in full payment of convertible loans totaling $1,202,000 and related accrued interest totaling $568,400.
Common Stock Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants outstanding						38,208,320
Stock price (in Dollars per share)						$ 0.03
Series A Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares designated						150,000			150,000
Preferred stock stated value (in Dollars per share)						$ 10
Conversion price (in Dollars per share)						$ 0.10
Preferred Stock, shares issued		45,000				0			82,500
Number of shares issued	27,500
Aggregate value of conversion of units (in Dollars)	$ 275,000
Preferred stock, outstanding						0			82,500
Percentage of outstanding shares			100.00%
Non cash loss (in Dollars)			$ 1,735,500
Securities Purchase Agreements [Member] | Warrant [Member] | Two Accredited Investors [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued		9,000,000
Value of shares converted (in Dollars)								650,421
Warrant charge against additional paid in capital (in Dollars)								450,000
Change in fair value of warrant liability (in Dollars)								$ 200,421
Securities Purchase Agreements [Member] | Warrant [Member] | Accredited Investors [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued					2,000,000
Warrants exercise price (in Dollars per share)	$ 0.15
Warrant exercisable term	5 years
Securities Purchase Agreements [Member] | Series A Preferred Stock [Member] | Two Accredited Investors [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares converted		4,500,000
Securities Purchase Agreements [Member] | Series A Preferred Stock [Member] | Accredited Investors [Member]
Stockholders' Equity (Details) [Line Items]
Number of shares issued					10,000
Exchange Agreements [Member] | Series A Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Conversion of shares			75,000,000